Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 49

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 49
---
 results of operations may be adversely affected by COVID-19 or similar global pandemic. A significant outbreak, epidemic or pandemic of contagious diseases in any geographic area in which we operate or plan to operate could result in a health crisis adversely affecting the economies, financial markets and overall demand for our services in such areas. In addition, any preventative or protective actions that governments implement or that we take in response to a health crisis, such as travel restrictions, quarantines, or site closures, may interfere with the ability of our employees, suppliers and customers to perform their responsibilities. Such results could have a material adverse effect on our business. COVID-19 created significant volatility, uncertainty and economic disruption. To date, COVID-19 has affected nearly all regions around the world. In the United States, businesses as well as federal, state and local governments implemented significant actions to mitigate this public health crisis. While we cannot predict the duration or scope of COVID-19, it may negatively impact our business and such impact could be material to our financial results, condition and outlook related to:

| ● | disruption                                                                                                                                    
 to our operations or the operations of our suppliers, through the effects of business and facilities closures, worker sickness and COVID-19   
 related inability to work, social, economic, political or labor instability in affected areas, transportation delays, difficulty in enrolling 
 patients, travel restrictions and changes in operating procedures, including for additional cleaning and safety protocols;                    |

| ● | increased                                                                                                                                 
 volatility or significant disruption of global financial markets due in part to any future COVID-19 outbreak, which could have a negative 
 impact on our ability to access capital markets and other funding sources, on acceptable terms or at all and impede our ability to comply 
 with debt covenants; and                                                                                                                  |

| ● | the                                                                                                                                           
 further spread of COVID-19, and the requirements to take action to mitigate the spread of any future COVID-19 outbreak (e.g., hygiene         
 requirements or social distancing or other measures), will impact our ability to carry out our business as usual and may materially adversely 
 impact global economic conditions, our business, results of operations, cash flows and financial condition.                                   |

To the extent COVID-19 or a similar public health threat has an impact on our business, it is likely to also have the effect of heightening many of the other risks described in this “ Risk Factors” section. U.S. public sector procurement of Arakoda might not materialize in the future, which could jeopardize our business. Sales to the U